← Back to Search

Test Group 3 for Pulse Oximetry (FAST 2024 Trial)

N/A
Waitlist Available
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up may-august 2024
Awards & highlights

Summary

Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~may-august 2024
This trial's timeline: 3 weeks for screening, Varies for treatment, and may-august 2024 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
SpO2 Accuracy
Secondary study objectives
Non-Disparate Bias

Trial Design

4Treatment groups
Experimental Treatment
Group I: Test Group 4Experimental Treatment1 Intervention
* M1133A (989803205851) * EX-M1133A (Experimental) * M1196T (989803205911) * EX-M1196T (Experimental) * M1191BL (989803144381) as an internal reference only (optional)
Group II: Test Group 3Experimental Treatment1 Intervention
* EX-Alar on Nasal Ala (Experimental) * EX-Alar on Ear (Experimental) * M1191BL (989803144381) as an internal reference only
Group III: Test Group 2Experimental Treatment1 Intervention
* M1194A (989803205891) * Alar (989803205381) * M1191BL (989803144381) as an internal reference only
Group IV: Test Group 1Experimental Treatment1 Intervention
* M1131A (989803205831) * M1191T (989803128591) * M1191BL (989803144381) for endpoint analysis * M1193A (989803205881)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
No Intervention
2017
Completed Phase 1
~4810

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor
53 Previous Clinical Trials
16,804 Total Patients Enrolled
~64 spots leftby Sep 2025